Tag: immuno-oncology
February 25, 2019
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
CRISPR Therapeutics (NASDAQ:CRSP) has announced financial results for its fourth quarter and full year ended December 31, 2018. As quoted... January 29, 2019
Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
January 24, 2019
Jeff Bockman: The State and Future of Immunotherapies
Jeff Bockman with Cello Health Bioconsulting dives into the immunotherapy industry, from what’s going on now to what’s to come.
December 26, 2018
5 Top Genetics News Stories of 2018
What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...
December 19, 2018
Biotech Outlook 2019: Will the Pressure Continue?
With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy? October 18, 2018